Related references
Note: Only part of the references are listed.Immune cells regulate VEGF signalling via release of VEGF and antagonistic soluble VEGF receptor-1
T. Hoeres et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2018)
NKG2D ligands in glioma stem-like cells: expression in situ and in vitro
Charlotte Flueh et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2018)
Prevention of Vγ9Vδ2 T Cell Activation by a Vγ9Vδ2 TCR Nanobody
Renee C. G. de Bruin et al.
JOURNAL OF IMMUNOLOGY (2017)
Low-dose bortezomib increases the expression of NKG2D and DNAM-1 ligands and enhances induced NK and γδ T cell-mediated lysis in multiple myeloma
Chao Niu et al.
ONCOTARGET (2017)
The butyrophilin 3A1 intracellular domain undergoes a conformational change involving the juxtamembrane region
Khiem Nguyen et al.
FASEB JOURNAL (2017)
Phosphoantigen-induced conformational change of butyrophilin 3A1 (BTN3A1) and its implication on Vγ9Vδ2 T cell activation
Siyi Gu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
CD20-Specific Immunoligands Engaging NKG2D Enhance γδ T Cell-Mediated Lysis of Lymphoma Cells
M. Peipp et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2017)
The ATP-binding cassette transporter A1 regulates phosphoantigen release and Vγ9Vδ2 T cell activation by dendritic cells
Barbara Castella et al.
NATURE COMMUNICATIONS (2017)
Expression of LAG-3 defines exhaustion of intratumoral PD-1+ T cells and correlates with poor outcome in follicular lymphoma
Zhi-Zhang Yang et al.
ONCOTARGET (2017)
Squamous Cell Tumors Recruit γδ T Cells Producing either IL17 or IFNγ Depending on the Tumor Stage
Elena Lo Presti et al.
CANCER IMMUNOLOGY RESEARCH (2017)
PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
Hashem O. Alsaab et al.
FRONTIERS IN PHARMACOLOGY (2017)
Metabolic Hallmarks of Tumor and immune Cells in the Tumor Microenvironment
Kathrin Renner et al.
FRONTIERS IN IMMUNOLOGY (2017)
Current Advances in γδ T Cell-Based Tumor Immunotherapy
Elena Lo Presti et al.
FRONTIERS IN IMMUNOLOGY (2017)
Combining Vγ9Vδ2 T Cells with a Lipophilic Bisphosphonate Efficiently Kills Activated Hepatic Stellate Cells
Xiaoying Zhou et al.
Frontiers in Immunology (2017)
Mevalonate metabolism governs cancer immune surveillance
Georg Gruenbacher et al.
ONCOIMMUNOLOGY (2017)
Assessment of tumor-infiltrating TCRVγ9Vδ2 γδ lymphocyte abundance by deconvolution of human cancers microarrays
Marie Tosolini et al.
ONCOIMMUNOLOGY (2017)
Distinctive features of tumor-infiltrating γδ T lymphocytes in human colorectal cancer
S. Meraviglia et al.
ONCOIMMUNOLOGY (2017)
Enhancing adoptive cancer immunotherapy with VΥ2Vδ2 T cells through pulse zoledronate stimulation
Mohanad H. Nada et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Vδ2+T cell response to malaria correlates with protection from infection but is attenuated with repeated exposure
Prasanna Jagannathan et al.
SCIENTIFIC REPORTS (2017)
Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug
Yoshimasa Tanaka et al.
SCIENTIFIC REPORTS (2017)
Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma
Christopher D. Carey et al.
BLOOD (2017)
Vγ9Vδ2 T cell activation by strongly agonistic nucleotidic phosphoantigens
Morgane Moulin et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
Zoledronic acid renders human M1 and M2 macrophages susceptible to Vδ2+ γδ T cell cytotoxicity in a perforin-dependent manner
Daniel W. Fowler et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Adoptively transferred Vγ9Vδ2 T cells show potent antitumor effects in a preclinical B cell lymphomagenesis model
Nicholas A. Zumwalde et al.
JCI INSIGHT (2017)
Butyrophilin 3A (BTN3A, CD277)-specific antibody 20.1 differentially activates Vγ9Vδ2 TCR clonotypes and interferes with phosphoantigen activation
Lisa Starick et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Nano-technology based carriers for nitrogen-containing bisphosphonates delivery as sensitisers of γδ T cells for anticancer immunotherapy
Naomi O. Hodgins et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Adjuvant combination therapy with gemcitabine and autologous γδ T-cell transfer in patients with curatively resected pancreatic cancer
Taku Aoki et al.
CYTOTHERAPY (2017)
Human γδ T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infection
Sarina Ravens et al.
NATURE IMMUNOLOGY (2017)
Adoptive transfer of ex vivo expanded Vγ9Vδ2 T cells in combination with zoledronic acid inhibits cancer growth and limits osteolysis in a murine model of osteolytic breast cancer
Aneta Zysk et al.
CANCER LETTERS (2017)
Vγ9Vδ2 T cells and zoledronate mediate antitumor activity in an orthotopic mouse model of human chondrosarcoma
L. Sun et al.
TUMOR BIOLOGY (2016)
Effective combination treatment of GD2-expressing neuroblastoma and Ewing's sarcoma using anti-GD2 ch14.18/CHO antibody with Vγ9Vδ2+γδT cells
Jonathan P. H. Fisher et al.
ONCOIMMUNOLOGY (2016)
NKG2D-and T-cell receptor-dependent lysis of malignant glioma cell lines by human T cells: Modulation by temozolomide and A disintegrin and metalloproteases 10 and 17 inhibitors
Guranda Chitadze et al.
ONCOIMMUNOLOGY (2016)
PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance
Alessandra Dondero et al.
ONCOIMMUNOLOGY (2016)
γδ T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation
Donnele Daley et al.
CELL (2016)
Targeting Cancer Cells with a Bisphosphonate Prodrug
Kenji Matsumoto et al.
CHEMMEDCHEM (2016)
Highly specific and potently activating Vγ9Vδ2-T cell specific nanobodies for diagnostic and therapeutic applications
Renee C. G. de Bruin et al.
CLINICAL IMMUNOLOGY (2016)
Proportions of blood-borne Vδ1+and Vδ2+T-cells are associated with overall survival of melanoma patients treated with ipilimumab
Kilian Wistuba-Hamprecht et al.
EUROPEAN JOURNAL OF CANCER (2016)
Regulatory and effector functions of gamma-delta (γδ) T cells and their therapeutic potential in adoptive cellular therapy for cancer
Sourav Paul et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Membrane-bound versus soluble major histocompatibility complex Class I-related chain A and major histocompatibility complex Class I-related chain B differential expression: Mechanisms of tumor eradication versus evasion and current drug development strategies
P. K. Suresh
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2016)
HMBPP Analog Prodrugs Bypass Energy-Dependent Uptake To Promote Efficient BTN3A1-Mediated Malignant Cell Lysis by Vγ9Vδ2 T Lymphocyte Effectors
Ashley M. Kilcollins et al.
JOURNAL OF IMMUNOLOGY (2016)
Prolonged PD1 Expression on Neonatal Vδ2 Lymphocytes Dampens Proinflammatory Responses: Role of Epigenetic Regulation
Haoting Hsu et al.
JOURNAL OF IMMUNOLOGY (2016)
Inversion of the Vδ1 to Vδ2 γδ T cell ratio in CVID is not restored by IVIg and is associated with immune activation and exhaustion
Dominic Paquin-Proulx et al.
MEDICINE (2016)
In vivo expansion and activation of T cells as immunotherapy for refractory neuroblastoma: A phase 1 study
Joseph G. Pressey et al.
MEDICINE (2016)
Emerging concepts of T cell metabolism as a target of immunotherapy
Chih-Hao Chang et al.
NATURE IMMUNOLOGY (2016)
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
Vassiliki A. Boussiotis
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials
Heleen. H. Van Acker et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Heterogeneous yet stable Vδ2(+) T-cell profiles define distinct cytotoxic effector potentials in healthy human individuals
Paul L. Ryan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
Shohei Koyama et al.
NATURE COMMUNICATIONS (2016)
CD19-specific triplebody SPM-1 engages NK and gd T cells for rapid and efficient lysis of malignant B-lymphoid cells
Christian B. Schiller et al.
ONCOTARGET (2016)
Ecto-ATPase CD39 Inactivates Isoprenoid-Derived Vγ9Vδ2 T Cell Phosphoantigens
Georg Gruenbacher et al.
CELL REPORTS (2016)
RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell Receptor
Zsolt Sebestyen et al.
CELL REPORTS (2016)
Stereotaxic administrations of allogeneic human Vγ9Vδ2 T cells efficiently control the development of human glioblastoma brain tumors
Ulrich Jarry et al.
ONCOIMMUNOLOGY (2016)
BTN3A molecules considerably improve V9V2T cells-based immunotherapy in acute myeloid leukemia
Audrey Benyamine et al.
ONCOIMMUNOLOGY (2016)
L-asparaginase in the treatment of patients with acute lymphoblastic leukemia
Rachel A. Egler et al.
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS (2016)
In vitro analysis of the proliferative capacity and cytotoxic effects of ex vivo induced natural killer cells, cytokine-induced killer cells, and gamma-delta T cells
Chao Niu et al.
BMC IMMUNOLOGY (2015)
γδ T cell activation by bispecific antibodies
Hans-Heinrich Oberg et al.
CELLULAR IMMUNOLOGY (2015)
Evolution and function of the TCR Vgamma9 chain repertoire: It's good to be public
C. David Pauza et al.
CELLULAR IMMUNOLOGY (2015)
VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors
Thibault Voron et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Sensor Function for Butyrophilin 3A1 in Prenyl Pyrophosphate Stimulation of Human Vγ2Vδ2 T Cells
Hong Wang et al.
JOURNAL OF IMMUNOLOGY (2015)
IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
Seth B. Coffelt et al.
NATURE (2015)
The prognostic landscape of genes and infiltrating immune cells across human cancers
Andrew J. Gentles et al.
NATURE MEDICINE (2015)
Effector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoire
Tanya Dimova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
Five layers of receptor signaling in γδ T-cell differentiation and activation
SergioT. Ribeiro et al.
FRONTIERS IN IMMUNOLOGY (2015)
γδ T cells and epigenetic drugs: A useful merger in cancer immunotherapy?
Jaydeep Bhat et al.
ONCOIMMUNOLOGY (2015)
Resistance of cyclooxygenase-2 expressing pancreatic ductal adenocarcinoma cells against γδ T cell cytotoxicity
Daniel Gonnermann et al.
ONCOIMMUNOLOGY (2015)
Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma
Barbara Castella et al.
ONCOIMMUNOLOGY (2015)
γδ T Cell Immunotherapy-A Review
Hirohito Kobayashi et al.
PHARMACEUTICALS (2015)
Opportunities and challenges in development of phosphoantigens as Vγ9Vδ2 T cell agonists
David F. Wiemer et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Dichloroacetate and cancer: New home for an orphan drug?
Shyam Kankotia et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2014)
Targeted Activation of Human Vγ9Vδ2-T Cells Controls Epstein-Barr Virus-Induced B Cell Lymphoproliferative Disease
Zheng Xiang et al.
CANCER CELL (2014)
Novel Bispecific Antibodies Increase γδ T-Cell Cytotoxicity against Pancreatic Cancer Cells
Hans-Heinrich Oberg et al.
CANCER RESEARCH (2014)
MICA polymorphism: biology and importance in cancer
Dan Chen et al.
CARCINOGENESIS (2014)
Neutrophil uptake of nitrogen-bisphosphonates leads to the suppression of human peripheral blood γδ T cells
Shirin Kalyan et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Phenotype and regulation of immunosuppressive Vδ2-expressing γδ T cells
Christian Peters et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Synthesis of a Phosphoantigen Prodrug that Potently Activates Vγ9Vδ2 T-Lymphocytes
Chia-Hung Christine Hsiao et al.
CHEMISTRY & BIOLOGY (2014)
Neuroblastoma Killing Properties of Vδ2 and Vδ2-Negative γδT Cells Following Expansion by Artificial Antigen-Presenting Cells
Jonathan P. H. Fisher et al.
CLINICAL CANCER RESEARCH (2014)
Programmed death-1 pathway in cancer and autoimmunity
Ariel Pedoeem et al.
CLINICAL IMMUNOLOGY (2014)
Upregulation of NKG2D ligands in acute lymphoblastic leukemia and non-Hodgkin lymphoma cells by romidepsin and enhanced in vitro and in vivo natural killer cell cytotoxicity
Prakash Satwani et al.
CYTOTHERAPY (2014)
γδT17 Cells Promote the Accumulation and Expansion of Myeloid-Derived Suppressor Cells in Human Colorectal Cancer
Pin Wu et al.
IMMUNITY (2014)
The Intracellular B30.2 Domain of Butyrophilin 3A1 Binds Phosphoantigens to Mediate Activation of Human Vγ9Vδ2 T Cells
Andrew Sandstrom et al.
IMMUNITY (2014)
Vγ9 and Vδ2 T cell antigen receptor genes and butyrophilin 3 (BTN3) emerged with placental mammals and are concomitantly preserved in selected species like alpaca (Vicugna pacos)
Mohindar M. Karunakaran et al.
IMMUNOGENETICS (2014)
Phosphoantigens and butyrophilin 3A1 induce similar intracellular activation signaling in human TCRVγ9+ γδ T lymphocytes
Emilie Decaup et al.
IMMUNOLOGY LETTERS (2014)
Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression-free survival for patients with hepatocellular carcinoma
Jiuwei Cui et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Metabolic Engineering of Salmonella Vaccine Bacteria To Boost Human Vγ2Vδ2 T Cell Immunity
Grefachew Workalemahu et al.
JOURNAL OF IMMUNOLOGY (2014)
IL-2: The First Effective Immunotherapy for Human Cancer
Steven A. Rosenberg
JOURNAL OF IMMUNOLOGY (2014)
A Comprehensive Analysis of Primary Acute Myeloid Leukemia Identifies Biomarkers Predicting Susceptibility to Human Allogeneic Vγ9Vδ2 T Cells
Stefan Gundermann et al.
JOURNAL OF IMMUNOTHERAPY (2014)
Successful adoptive transfer and in vivo expansion of haploidentical γδ T cells
Martin Wilhelm et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Murine CD27(-) Vγ6(+) γδ T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophages
Margarida Rei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Intraperitoneal injection of in vitro expanded Vγ9Vδ2 T cells together with zoledronate for the treatment of malignant ascites due to gastric cancer
Ikuo Wada et al.
CANCER MEDICINE (2014)
The Vγ9Vδ2T cell antigen receptor and butyrophilin-3 A1: models of interaction, the possibility of co-evolution, and the case of dendritic epidermalT cells
Mohindar M. Karunakaran et al.
FRONTIERS IN IMMUNOLOGY (2014)
Potential use of γδ T cell-based vaccines in cancer immunotherapy
Mohd Wajid A. Khan et al.
FRONTIERS IN IMMUNOLOGY (2014)
γδT cell-meciated antibody-dependent cellular cytotoxicity with CD19 antibodies assessed by an impedance-based label-free real-time cytotoxicity assay
Ursula Joerdis Eva Seidel et al.
FRONTIERS IN IMMUNOLOGY (2014)
Plasticity of γδT cells: impact on the anti-tumor response
Virginie Lafont et al.
FRONTIERS IN IMMUNOLOGY (2014)
Tumor-infiltrating γδ T lymphocytes: pathogenic role, clinical significance, and differential programing in tumor microenvironment
Elena Lo Presti et al.
FRONTIERS IN IMMUNOLOGY (2014)
gamma delta T cells for cancer immunotherapy A systematic review of clinical trials
Jonathan P. H. Fisher et al.
ONCOIMMUNOLOGY (2014)
Stress-related and homeostatic cytokines regulate Vγ9Vδ2 T-cell surveillance of mevalonate metabolism
Georg Gruenbacher et al.
ONCOIMMUNOLOGY (2014)
The co-receptor BTLA negatively regulates human Vγ9Vδ2 T-cell proliferation: a potential way of immune escape for lymphoma cells
Julie Gertner-Dardenne et al.
BLOOD (2013)
Human CD3γ, but not CD3δ, haploinsufficiency differentially impairs γδ versus αβ surface TCR expression
Miguel Munoz-Ruiz et al.
BMC IMMUNOLOGY (2013)
Comparison of T cell responses and farnesyl diphosphate synthase inhibition in tumor cells pretreated with zoledronic acid
Atif S. M. Idrees et al.
CANCER SCIENCE (2013)
Ex vivo characterization of γδ T-cell repertoire in patients after adoptive transfer of Vγ9Vδ2 T cells expressing the interleukin-2 receptor β-chain and the common γ-chain
Takamichi Izumi et al.
CYTOTHERAPY (2013)
Human V2V2 T cells limit breast cancer growth by modulating cell survival-, apoptosis-related molecules and microenvironment in tumors
Reeva Aggarwal et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
The functional impairment of HCC-infiltrating γδ T cells, partially mediated by regulatory T cells in a TGFβ- and IL-10-dependent manner
Yong Yi et al.
JOURNAL OF HEPATOLOGY (2013)
Repeated Systemic Administrations of Both Aminobisphosphonates and Human Vγ9Vδ2 T Cells Efficiently Control Tumor Development In Vivo
Thibault Santolaria et al.
JOURNAL OF IMMUNOLOGY (2013)
Butyrophilin 3A1 Plays an Essential Role in Prenyl Pyrophosphate Stimulation of Human V gamma 2V delta 2 T Cells
Hong Wang et al.
JOURNAL OF IMMUNOLOGY (2013)
Dacarbazine-Mediated Upregulation of NKG2D Ligands on Tumor Cells Activates NK and CD8 T Cells and Restrains Melanoma Growth
Alice Hervieu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
The activity of γδ T cells against paediatric liver tumour cells and spheroids in cell culture
Alexander Hoh et al.
LIVER INTERNATIONAL (2013)
Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells
Stefano Vavassori et al.
NATURE IMMUNOLOGY (2013)
Engineered Drug Resistant γδ T Cells Kill Glioblastoma Cell Lines during a Chemotherapy Challenge: A Strategy for Combining Chemo- and Immunotherapy
Lawrence S. Lamb et al.
PLOS ONE (2013)
Chemotherapy Sensitizes Colon Cancer Initiating Cells to Vγ9Vδ2 T Cell- Mediated Cytotoxicity
Matilde Todaro et al.
PLOS ONE (2013)
Six-of-the-best: unique contributions of γδ T cells to immunology
Pierre Vantourout et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells
Marta Coscia et al.
BLOOD (2012)
Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset
Christelle Harly et al.
BLOOD (2012)
Long-Term Effects of Amino-Bisphosphonates on Circulating γδ T Cells
Maurizio Rossini et al.
CALCIFIED TISSUE INTERNATIONAL (2012)
The gene expression profile of phosphoantigen-specific human ?d T lymphocytes is a blend of a ss T-cell and NK-cell signatures
Frederic Pont et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Tumor-Infiltrating γδ T Lymphocytes Predict Clinical Outcome in Human Breast Cancer
Chunling Ma et al.
JOURNAL OF IMMUNOLOGY (2012)
Tumor-promoting Versus Tumor-antagonizing Roles of γδ T Cells in Cancer Immunotherapy: Results From a Prospective Phase I/II Trial
Volker Kunzmann et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Characterization of Human γδ T Lymphocytes Infiltrating Primary Malignant Melanomas
Adriana Cordova et al.
PLOS ONE (2012)
Redirecting αβT cells against cancer cells by transfer of a broadly tumor-reactive γδT-cell receptor
Victoria Marcu-Malina et al.
BLOOD (2011)
Differentiation, phenotype, and function of interleukin-17-producing human Vγ9Vδ2 T cells
Nadia Caccamo et al.
BLOOD (2011)
Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours
A. J. Nicol et al.
BRITISH JOURNAL OF CANCER (2011)
Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma
Hirohito Kobayashi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma
Joshua M. Lang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Cancer Immunotherapy Using a Bispecific NK Receptor Fusion Protein that Engages both T Cells and Tumor Cells
Tong Zhang et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Zoledronate-activated V gamma 9 gamma delta T cell-based immunotherapy is feasible and restores the impairment of gamma delta T cells in patients with solid tumors
Atsutaka Noguchi et al.
CYTOTHERAPY (2011)
Differential role for CD277 as a co-regulator of the immune signal in T and NK cells
Nassima Messal et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens
Masashi Iwasaki et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
γδ T-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibody
Mounia Sabrina Braza et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Upregulation of NKG2D ligands and enhanced natural killer cell cytotoxicity by hydralazine and valproate
A. Chavez-Blanco et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2011)
Stimulated γδ T Cells Increase the In Vivo Efficacy of Trastuzumab in HER-2+ Breast Cancer
Aude-Helene Capietto et al.
JOURNAL OF IMMUNOLOGY (2011)
Adoptive Immunotherapy for Advanced Non-small Cell Lung Cancer Using Zoledronate-expanded γδ T Cells: A Phase I Clinical Study
Miki Sakamoto et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Anti-Leukemia Activity of In Vitro-Expanded Human Gamma Delta T Cells in a Xenogeneic Ph+ Leukemia Model
Gabrielle M. Siegers et al.
PLOS ONE (2011)
Evolution of the V, D, and J gene segments used in the primate γδ T-cell receptor reveals a dichotomy of conservation and diversity
Allison R. Kazen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
An NKG2D-Mediated Human Lymphoid Stress Surveillance Response with High Interindividual Variation
Seema Shafi et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Lipophilic Pyridinium Bisphosphonates: Potent gamma delta T Cell Stimulators
Yonghui Zhang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Effect of vascular endothelial growth factor and its receptor KDR on the transendothelial migration and local trafficking of human T cells in vitro and in vivo
Monika Edelbauer et al.
BLOOD (2010)
Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity
Ekkehard Moessner et al.
BLOOD (2010)
Adoptively transferred ex vivo expanded γδ-T cells mediate in vivo antitumor activity in preclinical mouse models of breast cancer
Benjamin H. Beck et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vγ9Vδ2 T lymphocyte agonist in patients with solid tumors
Jaafar Bennouna et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
In vivo manipulation of Vγ9Vδ2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients
S. Meraviglia et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous γδ T cells
Jun Nakajima et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2010)
Tumor-infiltrating IL-17-producing γδ T cells support the progression of tumor by promoting angiogenesis
Daiko Wakita et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
Kaori Sakuishi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Vγ9Vγ2 T Lymphocytes Efficiently Recognize and Kill Zoledronate-Sensitized, Imatinib-Sensitive, and Imatinib-Resistant Chronic Myelogenous Leukemia Cells
Matilde D'Asaro et al.
JOURNAL OF IMMUNOLOGY (2010)
V gamma 2V delta 2 T Cell Receptor Recognition of Prenyl Pyrophosphates Is Dependent on All CDRs
Hong Wang et al.
JOURNAL OF IMMUNOLOGY (2010)
Cytokine Requirements for the Differentiation and Expansion of IL-17A-and IL-22-Producing Human Vγ2Vδ2 T Cells
Kristin J. Ness-Schwickerath et al.
JOURNAL OF IMMUNOLOGY (2010)
First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial
Gareth J. Morgan et al.
LANCET (2010)
Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies
Julie Gertner-Dardenne et al.
BLOOD (2009)
The NKG2D ligand ULBP4 binds to TCRγ9/δ2 and induces cytotoxicity to tumor cells through both TCRγδ and NKG2D
Yan Kong et al.
BLOOD (2009)
Peripheral blood monocytes are responsible for gamma delta T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP
Anke J. Roelofs et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vγ9Vδ2 T cells
Olivier Toutirais et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Defective γδ T-cell function and granzyme B gene polymorphism in a cohort of newly diagnosed breast cancer patients
Ameera Gaafar et al.
EXPERIMENTAL HEMATOLOGY (2009)
Clinical and immunological evaluation of zoledronate-activated Vγ9γδ T-cell-based immunotherapy for patients with multiple myeloma
Yu Abe et al.
EXPERIMENTAL HEMATOLOGY (2009)
NKG2D and its ligands
Peyman Obeidy et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Analysis of endogenous ATP analogs and mevalonate pathway metabolites in cancer cell cultures using liquid chromatography-electrospray ionization mass spectrometry
Marjo Jauhiainen et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2009)
Serum Vascular Endothelial Growth Factor and Fibronectin Predict Clinical Response to High-Dose Interleukin-2 Therapy
Marianna Sabatino et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Efficient Killing of Human Colon Cancer Stem Cells by gamma delta T Lymphocytes
Matilde Todaro et al.
JOURNAL OF IMMUNOLOGY (2009)
Immunoactivation in preeclampsia: Vδ2+and regulatory T cells during the inflammatory stage of disease
Eva Miko et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2009)
Adverse Effects of Bisphosphonates: Implications for Osteoporosis Management
Kurt A. Kennel et al.
MAYO CLINIC PROCEEDINGS (2009)
Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma
Jaafar Bennouna et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
CD16+ γδ T cells mediate antibody dependent cellular cytotoxicity:: Potential mechanism in the pathogenesis of multiple sclerosis
Zhihong Chen et al.
CLINICAL IMMUNOLOGY (2008)
V gamma 9V delta 2 T cell cytotoxicity against tumor cells is enhanced by monoclonal antibody drugs - Rituximab and trastuzumab
Hirotake Tokuyama et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Chemokine receptors expression and migration potential of tumor-infiltrating and peripheral-expanded Vγ9Vδ2 T cells from renal cell carcinoma patients
Emilie Viey et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Design, Synthesis, and Biological Evaluation of Novel Aminobisphosphonates Possessing an in Vivo Antitumor Activity Through a γδ-T Lymphocytes-Mediated Activation Mechanism
Danicle Simoni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Different composition of the human and the mouse γδT cell receptor explains different phenotypes of CD3γ and CD3δ immunodeficiencies
Gabrielle M. Siegers et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Promiscuity and the single receptor: NKG2D
Robert A. Eagle et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Lysis of a broad range of epithelial tumour cells by human γδ T cells:: Involvement of NK62D ligands and T-cell receptor- versus NKG2D-dependent recognition
P. Wrobel et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2007)
Chemotherapy and zoledronate sensitize solid tumour cells to Vγ9Vδ2 T cell cytotoxicity
Stephen R. Mattarollo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Targeting human γδ T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer
Francesco Dieli et al.
CANCER RESEARCH (2007)
Long term disease-free survival in acute leukemia patients recovering with increased γδ T cells after partiallymismatched related donor bone marrow transplantation
K. T. Godder et al.
BONE MARROW TRANSPLANTATION (2007)
Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study
Hirohito Kobayashi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vγ2Vδ2 T cells:: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens
Craig T. Morita et al.
IMMUNOLOGICAL REVIEWS (2007)
Soluble MIC is elevated in the serum of patients with pancreatic carcinoma diminishing γδ T cell cytotoxicity
Angela Maerten et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Gamma-delta T-cells in patients with squamous cell carcinoma of the head and neck
Murat Bas et al.
ORAL ONCOLOGY (2006)
CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms
RV Parry et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
In vivo immunomanipulation of Vγ9Vδ2 T cells with a synthetic phosphoantigen in a preclinical nonhuman primate model
H Sicard et al.
JOURNAL OF IMMUNOLOGY (2005)
Vγ9Vδ2 T cell response to colon carcinoma cells
M Corvaisier et al.
JOURNAL OF IMMUNOLOGY (2005)
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
S Gasser et al.
NATURE (2005)
Activation of Vγ9Vδ2 T cells by NKG2D
B Rincon-Orozco et al.
JOURNAL OF IMMUNOLOGY (2005)
Drug-induced expansion and differentiation of Vγ9Vδ2 T cells in vivo:: The role of exogenous IL-2
R Casetti et al.
JOURNAL OF IMMUNOLOGY (2005)
Professional antigen-presentation function by human γδ T cells
M Brandes et al.
SCIENCE (2005)
The activating NKG2D receptor assembles in the membrane with two signaling dimers into a hexameric structure
D Garrity et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Ex vivo expanded human Vγ9Vδ2+γδ-T cells mediate innate antitumor activity against human prostate cancer cells in vitro
ZY Liu et al.
JOURNAL OF UROLOGY (2005)
Phosphostim-activated γδ T cells kill autologous metastatic renal cell carcinoma
E Viey et al.
JOURNAL OF IMMUNOLOGY (2005)
Characterization of BT3 molecules belonging to the B7 family expressed on immune cells
E Compte et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Characterization of tumor reactivity of human Vγ9Vδ2 yδ T cells in vitro and in SCID mice in vivo
D Kabelitz et al.
JOURNAL OF IMMUNOLOGY (2004)
Flexible migration program regulates γδ T-cell involvement in humoral immunity
M Brandes et al.
BLOOD (2003)
Roles of the NKG2D immunoreceptor and its ligands
DH Raulet
NATURE REVIEWS IMMUNOLOGY (2003)
Induction of γδ T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo
F Dieli et al.
BLOOD (2003)
Differentiation of effector/memory Vδ2 T cells and migratory routes in lymph nodes or inflammatory sites
F Dieli et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
γδ T cells for immune therapy of patients with lymphoid malignancies
M Wilhelm et al.
BLOOD (2003)
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
N Watanabe et al.
NATURE IMMUNOLOGY (2003)
Human T cell receptor γδ cells recognize endogenous mevalonate metabolites in tumor cells
HJ Gober et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Patterns of chemokine receptor expression on peripheral blood γδ T lymphocytes:: Strong expression of CCR5 is a selective feature of Vδ2/Vγ9 γδ T cells
A Glatzel et al.
JOURNAL OF IMMUNOLOGY (2002)
Peripheral γδ T-cell deficit in nasopharyngeal carcinoma
BJ Zheng et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Adaptive immune response of Vγ2Vδ2+ T cells during mycobacterial infections
Y Shen et al.
SCIENCE (2002)
Regulation of cutaneous malignancy by γδ T cells
M Girardi et al.
SCIENCE (2001)
Structure of a human γδ T-cell antigen receptor
TJ Allison et al.
NATURE (2001)
Chemical synthesis and biological activity of bromohydrin pyrophosphate, a potent stimulator of human γδ T cells
E Espinosa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Essential requirement of antigen presentation by monocyte lineage cells for the activation of primary human γδ T cells by aminobisphosphonate antigen
F Miyagawa et al.
JOURNAL OF IMMUNOLOGY (2001)
Cutting edge:: Human γδ T cells are activated by intermediates of the 2-C-methyl-D-erythritol 4-phosphate pathway of isoprenoid biosynthesis
B Altincicek et al.
JOURNAL OF IMMUNOLOGY (2001)
Human γδ+ T lymphocytes have in vitro graft vs leukemia activity in the absence of an allogeneic response
LS Lamb et al.
BONE MARROW TRANSPLANTATION (2001)
Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells
V Groh et al.
NATURE IMMUNOLOGY (2001)
γδ T cell receptor repertoire in blood and colonic mucosa of rhesus macaques
E Rakasz et al.
JOURNAL OF MEDICAL PRIMATOLOGY (2000)
Antigen recognition by human γδ T cells:: pattern recognition by the adaptive immune system
CT Morita et al.
SPRINGER SEMINARS IN IMMUNOPATHOLOGY (2000)
Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages
A Diefenbach et al.
NATURE IMMUNOLOGY (2000)
Human gamma delta T lymphocytes exert natural and IL-2-induced cytotoxicity to neuroblastoma cells
KE Schilbach et al.
JOURNAL OF IMMUNOTHERAPY (2000)
Share Paper
